Preclinical Animal Study and Human Clinical Trial Data of Co-Electrospun Poly(l-Lactide-co-caprolactone) and Fibrinogen Mesh for Anterior Pelvic Floor Reconstruction.
Xujun Wu,Yuru Wang,Cancan Zhu,Xiaowen Tong,Ming Yang,Li Yang,Zhang Liu,Weihong Huang,Feng Wu,Honghai Zong,Huaifang Li,Hongbing He
DOI: https://doi.org/10.2147/ijn.s88803
IF: 7.033
2016-01-01
International Journal of Nanomedicine
Abstract:Synthetic and biological materials are commonly used for pelvic floor reconstruction. In this study, host tissue response and biomechanical properties of mesh fabricated from co-electrospun poly(L-lactide-co-caprolactone) (PLCL) and fibrinogen (Fg) were compared with those of polypropylene mesh (PPM) in a canine abdominal defect model. Macroscopic, microscopic, histological, and biomechanical evaluations were performed over a 24-week period. The results showed that PLCL/Fg mesh had similar host tissue responses but better initial vascularization and graft site tissue organization than PPM. The efficacy of the PLCL/Fg mesh was further examined in human pelvic floor reconstruction. Operation time, intraoperative blood loss, and pelvic organ prolapse quantification during 6-month follow-up were compared for patients receiving PLCL/Fg mesh versus PPM. According to the pelvic organ prolapse quantification scores, the anterior vaginal wall 3 cm proximal to the hymen point (Aa point), most distal edge of the cervix or vaginal cuff scar point (C point), and posterior fornix point (D point) showed significant improvement (P<0.01) at 1, 3, and 6 months for both groups compared with preoperatively. At 6 months, improvements at the Aa point in the PLCL/Fg group were significantly more (P<0.005) than the PPM group, indicating that, while both materials improve the patient symptoms, PLCL/Fg mesh resulted in more obvious improvement.